ArticleArthritis research & therapy2025

Safety of JAK inhibitors versus other biologic therapies following anti-TNF failure in patients with rheumatoid arthritis.

Lorenzo Di Luozzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.